Development of telemedicine has been for many years, but in the past few years, the US market was a great development, which is mainly due to the payer fees for power control to support the development in the price dominant telemedicine. However, policy makers still have a more cautious attitude in the definition of telemedicine. For example, Medicare Medicare has only supported remote consultation on the BC side in suburban and rural areas. This telemedicine behavior is strictly prohibited in urban areas. . But with the promotion of value-based medicine, federal health insurance may announce a full-scale remote consultation on the BC side this year. However, the administrative and legislative bodies of the US states have different attitudes toward telemedicine. For example, the Texas Medical Board recently issued a decree prohibiting doctors from prescribing remotely to new patients who have not met. In California, such behavior is legal. The Texas practice led to a lawsuit filed by Texas-based telemedicine company Teladoc. To be exact, the Texas Medical Board's ban is only for users who have not established a doctor-patient relationship before the remote consultation, which is mainly considered for medical safety. The explosive growth of remote consultations in the United States is mainly due to the consultation of minor and chronic diseases. Therefore, the biggest blow to this ban is in ordinary cold and fever users, not chronically ill users. But minor illness is the most important source of remoteness, and it is also the core of Teladoc's strange remote consultation mode, so it has a greater impact. In the context of control fees, how to clearly define and find a policy balance point for telemedicine is the key. If all diseases are fully allowed for unfamiliar remote consultation, doctors do have a lot of uncertainties without knowing the patient well. However, it is difficult to define what type of disease is remotely evaluable. Therefore, relatively conservative policy makers will strictly limit the scope of remote consultation. But in terms of common sense, doctors in the United States have learned to protect themselves. In uncertain cases, they will certainly not give a diagnosis in a hurry, but will ask patients to go to the medical institutions under the line. Therefore, in general, the full liberalization of remote consultations in the United States does not lead to serious safety problems. Although there are many companies entering telemedicine in China, they have also attracted the attention of the market. However, due to the particularity of China's medical system, the development of remote consultation in China has not yet broken out. However, the government's restrictions on telemedicine have not changed, and the requirements are still only between medical institutions. Judging from China's national conditions, the policy of the Health Planning Commission has its rationality. First of all, China's telemedicine is more about profit-seeking, not from the perspective of control fees. Due to the long-term distortion of the price of medical services in China, the cost of offline consultation is relatively low, while the cost of online consultation is very high. In this case, the users of telemedicine are mainly patients with intractable diseases, and they are more likely to receive the services of famous doctors. This is destined to have a very narrow user base for telemedicine, and the motivation for doctor services is more to make money. However, for famous doctors, they are not short of money, so the willingness to conduct services online is not strong. Ordinary doctors are the mainstay of online consultation, but their ability to deal with incurable diseases is insufficient. Before these core contradictions cannot be resolved, it is necessary to limit the distance, because the mismatch between supply and demand can easily lead to disputes and thus harm the patient's interests. Secondly, there are few fees and service standards for medical treatment in China. Due to the long-term extensive management of medical insurance, the payment standards of Chinese medical insurance are not uniform across the country, especially for a variety of diseases without a standardized payment system. At the same time, the service capacity of medical institutions is extremely low, and there is not a complete set of service systems in the process of serving patients. The above two points seriously restrict the offline medical services. Once the online service is to be used to make use of existing medical services, this drawback is very obvious. Unlike telemedicine, which is standardized in the United States, China's current remote consultation and so-called Internet consulting market is very chaotic. Under such a status quo, not only is the patient at a loss, but it is also difficult for regulators to make standardized management. Finally, the relationship between doctors and patients in China is tense and the legal boundaries are blurred. For a long time, due to the difficulty of seeing a doctor and expensive medical treatment, the relationship between doctors and patients in China has always been very tense. The source of tension between doctors and patients is the patient’s distrust of doctors. The root of distrust is the system of medicine and medicine. Taking medicine to keep doctors makes it impossible for doctors to treat patients through more objective positions, which ultimately damages their image. But the root of this system is not the doctor itself, but the problem of the medical system. Therefore, under the premise that the medical reform has not touched on the core areas of reform, the tension between doctors and patients is difficult to alleviate. In this context, remote consultations are more likely to cause various types of disputes, leading to market disorder. Therefore, even if policy makers partially loosen the restrictions on telemedicine in the short term, problems will arise due to market confusion, and the final damage will still be the patient and the entire medical insurance payment system. In order to promote telemedicine can really benefit the public at an early date, the government should do the improvement of the offline medical insurance system as soon as possible, strengthen the fine management and control mechanism of medical insurance, and try to establish a set of diagnostic standards and service standard systems. Through this system, we can effectively supervise online and offline overall medical services. The policy balance of telemedicine in China depends more on the reform of the offline system. If the progress of the offline system reform is slow, it will greatly affect the development of telemedicine in China. Even if policy makers are no longer conservative, it is difficult for telemedicine to achieve real development. Therefore, the development of telemedicine in China still needs the government to really promote medical reform, in order to usher in the possibility of explosive growth in the market. Hydraulic Power Unit,Hydraulic Pump Unit,Hydraulic Power Station,Power Unit,Hydraulic Poppet Valve,Hydraulic Pilot Valve Changzhou Satidi Import and Export Co., Ltd. , https://www.guanjiejt.com